179. JAMA Oncol. 2018 Jul 1;4(7):1001-1003. doi: 10.1001/jamaoncol.2018.0813.Implications of Screening for Brain Metastases in Patients With Breast Cancer andNon-Small Cell Lung Cancer.Cagney DN(1), Martin AM(1), Catalano PJ(2)(3), Brown PD(4), Alexander BM(1), Lin NU(5), Aizer AA(1).Author information: (1)Department of Radiation Oncology, Dana-Farber/Brigham and Women's CancerCenter, Harvard Medical School, Boston, Massachusetts.(2)Department of Biostatistics, Harvard T.H. Chan School of Public Health,Boston, Massachusetts.(3)Department of Biostatistics and Computational Biology, Dana-Farber CancerInstitute, Boston, Massachusetts.(4)Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota.(5)Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.DOI: 10.1001/jamaoncol.2018.0813 PMID: 29799956 